GO:0110058 positive regulation of blood vessel endothelial cell differentiation: Signaling Pathways, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0110058 describes any process that activates or increases the frequency, rate or extent of blood vessel endothelial cell differentiation, a critical step in vasculogenesis and angiogenesis.
• Endothelial cell differentiation is driven by VEGF signaling, which promotes endothelial progenitor cell commitment and tube formation.
• Positive regulators include hypoxia-inducible factors such as EPAS1, which attenuates atherosclerosis by modulating endothelial fatty acid uptake.
• Macrophage-derived factors can induce endothelial-to-mesenchymal transition, a process that opposes endothelial differentiation in atheroma.
• Lymphatic endothelial cells in bone support regeneration after injury, highlighting the importance of endothelial differentiation in tissue repair.
• Single-cell RNA sequencing has revealed immune and non-immune cell interactions that influence endothelial differentiation in head and neck tumors.
Description
GO:0110058, positive regulation of blood vessel endothelial cell differentiation, is a biological process term that encompasses any molecular event that activates or increases the frequency, rate or extent of blood vessel endothelial cell differentiation. Endothelial cells line the inner surface of blood vessels and are essential for vascular development, homeostasis, and repair. The differentiation of endothelial cells from progenitor cells is a tightly regulated process that requires the coordinated action of growth factors, transcription factors, and extracellular matrix cues. Understanding the positive regulation of this process is fundamental to developmental biology, tissue regeneration, and cancer research, as aberrant endothelial differentiation contributes to pathologies such as atherosclerosis, tumor angiogenesis, and impaired wound healing. Recent studies have identified diverse molecular players that positively regulate endothelial differentiation, including vascular endothelial growth factors (VEGFs), hypoxia-inducible factors, and exosome-mediated signaling. For example, endothelial cell-derived exosomes trigger a positive feedback loop in osteogenesis-angiogenesis coupling by up-regulating zinc finger and BTB domain containing 16 in bone marrow mesenchymal stem cells. Moreover, lymphatic vessels in bone have been shown to support regeneration after injury, underscoring the therapeutic potential of targeting endothelial differentiation pathways. This article synthesizes current knowledge on the mechanisms, key genes, and research methodologies associated with GO:0110058, providing a comprehensive resource for researchers studying vascular biology and related diseases.
positive regulation of blood vessel endothelial cell differentiation At A Glance
| GO ID | GO:0110058 |
|---|---|
| GO term | positive regulation of blood vessel endothelial cell differentiation |
| Ontology | biological_process |
| Synonym | none |
| Major function | Promotes the differentiation of endothelial cells that form blood vessels |
| Related processes | Vasculogenesis, angiogenesis, endothelial cell migration, tube formation |
| Key regulators | VEGFs, HIFs, Notch, Wnt, exosomes |
| Disease relevance | Atherosclerosis, cancer, tissue regeneration, metabolic disorders |
What Is GO:0110058?
According to the Gene Ontology, GO:0110058 is defined as any process that activates or increases the frequency, rate or extent of blood vessel endothelial cell differentiation. In other words, it includes all molecular signals, pathways, and cellular events that promote the transition of endothelial progenitor cells or undifferentiated endothelial cells into mature, functional blood vessel endothelial cells. This term is a child of positive regulation of endothelial cell differentiation and is specific to blood vessel endothelial cells, distinguishing it from lymphatic endothelial cell differentiation. The process is essential for vasculogenesis, angiogenesis, and vascular remodeling, and it is regulated by a complex interplay of growth factors, transcription factors, and cell-cell interactions.
Why Is positive regulation of blood vessel endothelial cell differentiation Important in Cell Biology?
Positive regulation of blood vessel endothelial cell differentiation is crucial for normal development and tissue homeostasis, as it ensures the formation of a functional vascular network that supplies oxygen and nutrients to tissues. Dysregulation of this process is implicated in a wide range of diseases, including cancer, where tumor angiogenesis supports growth and metastasis, and atherosclerosis, where endothelial dysfunction contributes to plaque formation. Understanding the positive regulators of endothelial differentiation can reveal therapeutic targets for promoting revascularization after ischemic injury or inhibiting pathological angiogenesis in tumors. Furthermore, recent advances in single-cell technologies have highlighted the heterogeneity of endothelial cells and the complex intercellular communication that governs their differentiation in health and disease.
• Essential for embryonic development and organogenesis, as blood vessels form the first functional organ system.
• Critical for tissue repair and regeneration, including bone healing and wound healing.
• Plays a key role in tumor angiogenesis, where endothelial differentiation supports tumor growth and metastasis.
• Involved in atherosclerosis, where impaired endothelial differentiation and endothelial-to-mesenchymal transition contribute to plaque instability.
• Regulated by metabolic cues, such as fatty acid uptake via EPAS1, linking endothelial differentiation to lipid metabolism.
• Associated with hematological disorders in obesity, where lipotoxicity affects endothelial and hematopoietic lineages.
• VEGF signaling, a major positive regulator, is a therapeutic target in metabolic disorders and cancer.
• Exosome-mediated signaling between endothelial cells and mesenchymal stem cells promotes osteogenesis-angiogenesis coupling.
• Hypoxia and HIF pathways are potent inducers of endothelial differentiation and angiogenesis.
• Single-cell RNA sequencing has revealed diverse endothelial subtypes and their regulators in tumors.
What Happens During positive regulation of blood vessel endothelial cell differentiation?
Initiation by VEGF signaling
In simple terms: VEGF acts like a key that unlocks the differentiation program in endothelial cells.
Vascular endothelial growth factors (VEGFs) are the most well-characterized positive regulators of blood vessel endothelial cell differentiation. Upon binding to VEGFR2 on endothelial progenitor cells, VEGF triggers autophosphorylation of the receptor and activates downstream signaling cascades, including the PI3K/AKT and MAPK/ERK pathways. These pathways promote the expression of endothelial-specific transcription factors such as ETV2, FLI1, and KDR, driving the cells toward a differentiated endothelial phenotype. VEGF signaling also induces cell migration, proliferation, and tube formation, all of which are hallmarks of endothelial differentiation.
Transcriptional control by hypoxia-inducible factors
In simple terms: When oxygen is low, HIF proteins turn on genes that help endothelial cells mature.
Hypoxia-inducible factors (HIFs), particularly EPAS1 (HIF-2α), play a critical role in positively regulating endothelial differentiation under hypoxic conditions. EPAS1 attenuates atherosclerosis initiation at disturbed flow sites by promoting endothelial fatty acid uptake, which supports endothelial cell survival and function. HIFs induce the expression of angiogenic factors such as VEGFA and angiopoietins, creating a positive feedback loop that amplifies endothelial differentiation. This mechanism is essential for adaptive responses to ischemia and for tumor angiogenesis.
Exosome-mediated intercellular communication
In simple terms: Cells release tiny bubbles that carry signals to help endothelial cells differentiate.
Endothelial cell-derived exosomes have emerged as novel positive regulators of endothelial differentiation. These extracellular vesicles transfer proteins, mRNAs, and miRNAs to recipient cells, such as bone marrow mesenchymal stem cells, where they up-regulate zinc finger and BTB domain containing 16 (ZBTB16). This, in turn, promotes osteogenesis-angiogenesis coupling, a process where endothelial differentiation is coordinated with bone formation. Exosomes thus represent a mechanism for long-range positive regulation of endothelial differentiation in tissue regeneration.
Inhibition of endothelial-to-mesenchymal transition
In simple terms: Keeping endothelial cells from turning into other cell types helps maintain their identity.
Positive regulation of endothelial differentiation also involves suppressing pathways that drive endothelial-to-mesenchymal transition (EndMT). In atheroma, CD163+ macrophages induce EndMT, which leads to loss of endothelial markers and acquisition of mesenchymal traits, opposing endothelial differentiation. Conversely, factors that inhibit EndMT, such as TGF-β inhibitors or Notch activators, can promote the maintenance of the endothelial phenotype. Thus, the balance between differentiation and EndMT is a key determinant of vascular health.
Metabolic regulation by fatty acid uptake
In simple terms: How endothelial cells use fats affects their ability to differentiate.
Metabolic cues, particularly fatty acid uptake, positively regulate endothelial differentiation. EPAS1 (HIF-2α) promotes the expression of fatty acid transport proteins, enhancing endothelial fatty acid uptake and utilization. This metabolic adaptation supports the energy demands of differentiating endothelial cells and protects against atherosclerosis initiation at sites of disturbed flow. Dysregulation of this pathway, as seen in obesity-related lipotoxicity, can impair endothelial differentiation and contribute to hematological disorders.
Key Genes Involved in GO:0110058 positive regulation of blood vessel endothelial cell differentiation
The following genes and proteins are key players in the positive regulation of blood vessel endothelial cell differentiation, as supported by the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| VEGFA | Primary growth factor that activates VEGFR2 and drives endothelial differentiation | Target for pro-angiogenic therapy and cancer anti-angiogenesis |
| KDR (VEGFR2) | Receptor tyrosine kinase that mediates VEGF signaling in endothelial cells | Key mediator of endothelial differentiation; mutations affect vascular development |
| EPAS1 (HIF-2α) | Transcription factor that promotes endothelial fatty acid uptake and survival under hypoxia | Protective role in atherosclerosis; target for metabolic disorders |
| ZBTB16 | Transcription factor up-regulated by endothelial exosomes in mesenchymal stem cells | Mediates osteogenesis-angiogenesis coupling; potential target for bone regeneration |
| CD163 | Macrophage scavenger receptor that induces endothelial-to-mesenchymal transition | Opposes endothelial differentiation in atheroma; marker of macrophage polarization |
| FLT1 (VEGFR1) | Decoy receptor that modulates VEGF availability | Regulates the extent of endothelial differentiation; involved in preeclampsia |
| NOTCH1 | Transmembrane receptor that controls endothelial cell fate decisions | Balances tip and stalk cell differentiation during angiogenesis |
| DLL4 | Notch ligand that regulates endothelial sprouting | Involved in tumor angiogenesis; target for anti-angiogenic therapy |
| PECAM1 (CD31) | Adhesion molecule and endothelial marker | Used to identify differentiated endothelial cells |
| CDH5 (VE-cadherin) | Endothelial-specific adherens junction protein | Essential for endothelial barrier function and differentiation |
| ETV2 | Transcription factor that initiates endothelial gene expression | Master regulator of endothelial differentiation |
| FLI1 | ETS transcription factor that promotes endothelial gene expression | Required for endothelial differentiation and vascular development |
| PROX1 | Transcription factor for lymphatic endothelial differentiation | Distinguishes lymphatic from blood vessel endothelial differentiation |
| PGF (PlGF) | VEGF family member that modulates angiogenesis | Involved in pathological angiogenesis; potential therapeutic target |
| ANGPT2 | Angiopoietin that destabilizes vessels during angiogenesis | Regulates endothelial differentiation and vascular remodeling |
| TGFB1 | Cytokine that can induce EndMT and inhibit endothelial differentiation | Target for preventing EndMT in atherosclerosis |
| CXCR4 | Chemokine receptor that promotes endothelial progenitor cell homing | Involved in neovascularization after injury |
| NOS3 (eNOS) | Endothelial nitric oxide synthase | Marker of mature endothelial function; regulates vascular tone |
How Is positive regulation of blood vessel endothelial cell differentiation Regulated?
The positive regulation of blood vessel endothelial cell differentiation is controlled at multiple levels, including growth factor signaling, transcriptional regulation, and metabolic cues. VEGF signaling through VEGFR2 is the central positive regulator, activating downstream pathways such as PI3K/AKT and MAPK/ERK. Hypoxia-inducible factors, particularly EPAS1, transcriptionally up-regulate angiogenic genes and metabolic transporters, enhancing endothelial differentiation under low oxygen conditions. Exosome-mediated transfer of ZBTB16 from endothelial cells to mesenchymal stem cells creates a positive feedback loop that promotes osteogenesis-angiogenesis coupling. Conversely, TGF-β signaling can induce endothelial-to-mesenchymal transition, which negatively regulates endothelial differentiation. The balance between these positive and negative regulators determines the extent of endothelial differentiation in physiological and pathological contexts.
positive regulation of blood vessel endothelial cell differentiation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| EPAS1 | Atherosclerosis, metabolic disorders | Endothelial-specific knockout mouse, CRISPR point mutation in EPAS1 |
| CD163 | Atherosclerosis, inflammation | Macrophage-specific knockout, co-culture with endothelial cells |
| VEGFA | Cancer, ischemic disease | Inducible overexpression in endothelial cells, VEGF trap models |
| ZBTB16 | Bone regeneration, osteogenesis-angiogenesis coupling | Mesenchymal stem cell knockout, exosome transfer experiments |
| PROX1 | Lymphatic differentiation, bone regeneration | Lymphatic endothelial-specific knockout, bone injury models |
Atherosclerosis and endothelial dysfunction
Atherosclerosis is characterized by endothelial dysfunction and impaired endothelial differentiation. CD163+ macrophages in atheroma induce endothelial-to-mesenchymal transition, leading to loss of endothelial markers and plaque instability. EPAS1 attenuates atherosclerosis initiation at disturbed flow sites by promoting endothelial fatty acid uptake, suggesting that positive regulators of endothelial differentiation are protective. Targeting pathways that enhance endothelial differentiation or inhibit EndMT may offer therapeutic strategies for atherosclerosis.
Cancer and tumor angiogenesis
Tumor angiogenesis relies on the positive regulation of endothelial cell differentiation to form new blood vessels that supply the growing tumor. Single-cell RNA sequencing of head and neck tumors has revealed complex interactions between immune and non-immune cells that influence endothelial differentiation. VEGF signaling is a major driver of tumor angiogenesis, and anti-VEGF therapies are used clinically to inhibit this process. Understanding the positive regulators of endothelial differentiation in the tumor microenvironment can identify new targets for anti-angiogenic therapy.
Tissue regeneration and bone repair
Positive regulation of endothelial differentiation is essential for tissue regeneration, including bone repair. Lymphatic vessels in bone support regeneration after injury, highlighting the role of endothelial cells in skeletal repair. Endothelial cell-derived exosomes promote osteogenesis-angiogenesis coupling by up-regulating ZBTB16 in bone marrow mesenchymal stem cells, linking endothelial differentiation to bone formation. These findings suggest that enhancing endothelial differentiation could accelerate bone healing and regeneration.
Metabolic disorders and lipotoxicity
Metabolic disorders such as obesity are associated with lipotoxicity, which can impair endothelial differentiation and contribute to hematological disorders. VEGF signaling is altered in metabolic disorders, affecting endothelial function and angiogenesis. EPAS1-mediated fatty acid uptake is a protective mechanism that supports endothelial differentiation under metabolic stress. Therapeutic strategies that modulate endothelial differentiation may help mitigate vascular complications in metabolic diseases.
From positive regulation of blood vessel endothelial cell differentiation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X positively regulate endothelial differentiation? | CRISPR knockout of gene X in endothelial progenitor cells followed by differentiation assays |
| Does a specific point mutation in EPAS1 affect endothelial fatty acid uptake? | CRISPR point mutation knock-in in endothelial cells, lipid uptake assays |
| Can overexpression of ZBTB16 enhance osteogenesis-angiogenesis coupling? | Lentiviral overexpression in mesenchymal stem cells, co-culture with endothelial cells |
| What is the role of CD163+ macrophages in EndMT? | Macrophage-endothelial co-culture, CD163 knockout macrophages |
| How does VEGF signaling dose affect endothelial differentiation? | Inducible VEGF overexpression or knockout in zebrafish or mouse models |
| Can exosomes from endothelial cells promote bone regeneration? | Exosome isolation and transfer in bone injury mouse models |
How to Study the positive regulation of blood vessel endothelial cell differentiation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| scRNA-seq | Transcriptomic profiles of individual cells | Identifying endothelial subtypes and regulators |
| CRISPR knockout screening | Gene function on a genome-wide scale | Discovering novel positive regulators of endothelial differentiation |
| Proteomics | Protein expression and modifications | Quantifying signaling pathways during differentiation |
| Phosphoproteomics | Phosphorylation events | Mapping kinase signaling cascades |
| Live-cell imaging | Dynamic cellular behaviors | Visualizing tube formation and migration |
| Lineage tracing | Cell fate mapping in vivo | Tracking endothelial differentiation in bone regeneration |
| Exosome isolation and transfer | Intercellular communication | Studying exosome-mediated osteogenesis-angiogenesis coupling |
| EndMT assays | Endothelial-to-mesenchymal transition | Evaluating inhibitors of EndMT in atherosclerosis |
Single-cell RNA sequencing
Single-cell RNA sequencing (scRNA-seq) allows researchers to dissect the heterogeneity of endothelial cells and identify positive regulators of differentiation at the transcriptomic level. This method has been used to investigate immune and non-immune cell interactions in head and neck tumors, revealing endothelial subtypes and their regulators. scRNA-seq can also track the differentiation trajectory of endothelial progenitor cells and identify novel markers and pathways.
CRISPR screening
Genome-wide CRISPR screens enable unbiased discovery of positive regulators of endothelial differentiation. By knocking out every gene in the genome and assessing endothelial differentiation markers, researchers can identify novel regulators. This approach is particularly powerful for identifying genes that are not obvious candidates based on prior knowledge. EDITGENE offers custom CRISPR library screening services for such applications.
Proteomics and phosphoproteomics
Mass spectrometry-based proteomics and phosphoproteomics can quantify changes in protein expression and signaling events during endothelial differentiation. These methods can identify activated pathways, such as VEGF signaling, and reveal post-translational modifications that regulate endothelial differentiation.
Imaging and lineage tracing
Live-cell imaging and lineage tracing in zebrafish or mouse models allow visualization of endothelial differentiation in vivo. These techniques have been used to study lymphatic vessel regeneration in bone after injury and to track endothelial-to-mesenchymal transition in atherosclerosis. Imaging can also assess tube formation and vascular network development.
How CRISPR Can Be Used to Study GO:0110058 positive regulation of blood vessel endothelial cell differentiation
Knockout
CRISPR knockout is used to delete candidate genes and assess their requirement for endothelial differentiation. For example, knocking out EPAS1 in endothelial cells can reveal its role in fatty acid uptake and atherosclerosis protection. Knockout of CD163 in macrophages can test its role in inducing EndMT. EDITGENE provides custom knockout cell models for such studies.
Point Mutation
CRISPR point mutation knock-in allows the introduction of specific disease-associated mutations to study their impact on endothelial differentiation. For instance, point mutations in EPAS1 that affect its transcriptional activity can be modeled to understand their role in atherosclerosis. This approach is valuable for dissecting the precise molecular mechanisms of gene function.
Knock-in
CRISPR knock-in can be used to tag endogenous proteins with fluorescent markers or epitopes, enabling real-time tracking of endothelial differentiation. For example, knocking in a fluorescent tag at the ZBTB16 locus can visualize its up-regulation in mesenchymal stem cells upon exosome treatment. Knock-in of reporter genes under endothelial-specific promoters can also monitor differentiation.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression can be used to overexpress positive regulators of endothelial differentiation. Overexpressing VEGFA or EPAS1 can enhance endothelial differentiation and promote angiogenesis. Overexpression of ZBTB16 in mesenchymal stem cells can boost osteogenesis-angiogenesis coupling. EDITGENE offers overexpression cell models for such applications.
How EDITGENE Supports positive regulation of blood vessel endothelial cell differentiation Research
Researchers studying positive regulation of blood vessel endothelial cell differentiation-related genes often need to determine whether a candidate gene is causally involved in the process, and what its precise mechanism of action is. This requires robust genetic models that can knockout, mutate, knock-in, or overexpress the gene of interest in relevant cell types. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate such research.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of blood vessel endothelial cell differentiation research.
Frequently Asked Questions About positive regulation of blood vessel endothelial cell differentiation
What is GO:0110058?
GO:0110058 is a Gene Ontology biological process term defined as any process that activates or increases the frequency, rate or extent of blood vessel endothelial cell differentiation.
What genes are involved in positive regulation of blood vessel endothelial cell differentiation?
Key genes include VEGFA, KDR, EPAS1, ZBTB16, CD163, NOTCH1, DLL4, ETV2, and FLI1, among others.
How does VEGF signaling promote endothelial differentiation?
VEGF binds to VEGFR2, activating PI3K/AKT and MAPK/ERK pathways that induce endothelial-specific transcription factors and drive differentiation.
What is the role of EPAS1 in endothelial differentiation?
EPAS1 (HIF-2α) promotes endothelial fatty acid uptake and survival under hypoxia, attenuating atherosclerosis initiation at disturbed flow sites.
How do exosomes regulate endothelial differentiation?
Endothelial cell-derived exosomes transfer signals to mesenchymal stem cells, up-regulating ZBTB16 and promoting osteogenesis-angiogenesis coupling.
What is endothelial-to-mesenchymal transition (EndMT)?
EndMT is a process where endothelial cells lose their markers and acquire mesenchymal traits, opposing endothelial differentiation; it is induced by CD163+ macrophages in atheroma.
Which diseases are associated with dysregulated endothelial differentiation?
Atherosclerosis, cancer, metabolic disorders, and impaired tissue regeneration are associated with dysregulated endothelial differentiation.
How can I study positive regulators of endothelial differentiation?
Methods include CRISPR knockout screening, scRNA-seq, proteomics, and imaging; EDITGENE offers custom services for these approaches.
What CRISPR models are available for studying endothelial differentiation?
EDITGENE provides knockout, point mutation knock-in, tagged knock-in, overexpression, and CRISPR library screening services.
Why is positive regulation of endothelial differentiation important for bone regeneration?
Lymphatic vessels in bone support regeneration, and endothelial exosomes promote osteogenesis-angiogenesis coupling via ZBTB16, linking endothelial differentiation to bone repair.
Conclusion
GO:0110058, positive regulation of blood vessel endothelial cell differentiation, is a fundamental biological process that governs vascular development, tissue repair, and disease progression. The integration of VEGF signaling, hypoxia-inducible factors, exosome-mediated communication, and metabolic cues ensures proper endothelial differentiation, while its dysregulation contributes to atherosclerosis, cancer, and metabolic disorders. Advances in single-cell technologies and CRISPR screening are rapidly expanding our understanding of the positive regulators involved. EDITGENE's comprehensive CRISPR services, including knockout, point mutation, knock-in, overexpression, and library screening, provide researchers with powerful tools to dissect these mechanisms and develop novel therapeutic strategies.
References
- 1. Biswas L et al.. 2023. Lymphatic vessels in bone support regeneration after injury.. Cell 186(2):382-397.e24 PMID: 36669473
- 2. Kürten CHL et al.. 2021. Investigating immune and non-immune cell interactions in head and neck tumors by single-cell RNA sequencing.. Nat Commun 12(1):7338 PMID: 34921143
- 3. Mori M et al.. 2024. CD163(+) Macrophages Induce Endothelial-to-Mesenchymal Transition in Atheroma.. Circ Res 135(2):e4-e23 PMID: 38860377
- 4. Pirri D et al.. 2024. EPAS1 Attenuates Atherosclerosis Initiation at Disturbed Flow Sites Through Endothelial Fatty Acid Uptake.. Circ Res 135(8):822-837 PMID: 39234692
- 5. Haznedaroglu IC et al.. 2024. Lipotoxicity-Related Hematological Disorders in Obesity.. Adv Exp Med Biol 1460:575-594 PMID: 39287865
- 6. di Somma M et al.. 2020. Role of VEGFs in metabolic disorders.. Angiogenesis 23(2):119-130 PMID: 31853841
- 7. Liu L et al.. 2024. Endothelial cell-derived exosomes trigger a positive feedback loop in osteogenesis-angiogenesis coupling via up-regulating zinc finger and BTB domain containing 16 in bone marrow mesenchymal stem cell.. J Nanobiotechnology 22(1):721 PMID: 39563357
- 8. Patan S. 2004. Vasculogenesis and angiogenesis.. Cancer Treat Res 117:3-32 PMID: 15015550
